Compounded semaglutide cost: a transparent 2026 guide

Reputable U.S. telehealth clinics price compounded semaglutide between roughly $125 and $400 per month depending on format, dose, and included services. Alpine Health Rx starts at $125/month for the ODT (orally disintegrating tablet) format and $199/month for the injectable — both include provider oversight, supplies, and shipping. There are no lab fees or membership add-ons tacked on at checkout.

Brand-name semaglutide (Wegovy for weight loss, Ozempic for type 2 diabetes) lists at roughly $1,349 per month in the U.S. before insurance. Manufacturer savings cards can bring that closer to $650 for commercially insured patients who qualify, but the majority of adults seeking semaglutide for weight management do not have coverage — most commercial plans exclude anti-obesity medications outright, and Medicare Part D is prohibited by statute from covering weight-loss drugs.

For a patient paying cash, the delta is stark: about $1,349/month for brand Wegovy versus $125–$199/month for compounded semaglutide from a licensed telehealth provider. Over a 12-month treatment arc, that is roughly $16,000 versus $1,500–$2,400.

Three reasons. First, no brand markup — the raw pharmaceutical-grade semaglutide base is inexpensive; the retail price of Wegovy reflects R&D recovery, marketing, and rebate economics that don't apply to a 503A compound. Second, telehealth removes the in-person visit fee, the specialist referral chain, and the pharmacy retail margin. Third, direct-to-patient shipping eliminates the wholesaler and the storefront pharmacist.

The honest picture in 2026: most commercial plans do not cover semaglutide for weight loss, and none cover compounded semaglutide (compounds are patient-specific and don't carry NDCs, so they are ineligible for insurance billing). If you have Ozempic coverage for type 2 diabetes with a documented A1C, that is the exception, not the rule. For everyone else, cash-pay compounded is typically the only realistic path to sustained treatment.

When comparing telehealth clinics, look past the headline number and check whether the monthly price includes the licensed provider visit, dose titration, syringes and alcohol swabs for injectables, shipping, and provider messaging for dose adjustments. A $99/month teaser price that adds $75 for the visit, $25 for supplies, and $35 for shipping is not cheaper than a $199/month all-in quote — it's more expensive and less transparent.

A price under $100/month typically means one of three things: the active dose is unusually low, the pharmacy is not 503A-licensed or not doing potency testing, or the provider oversight is a rubber-stamp form review rather than a real intake. Any of the three is a reason to walk. Ask directly: is the pharmacy 503A-licensed and LegitScript-certified? Is every batch potency-tested? Is there a real provider I can message when my dose needs to change?

A realistic first-year budget on Alpine Health Rx compounded semaglutide: about $1,500 for the ODT ($125 × 12) or $2,388 for the injectable ($199 × 12), plus optional baseline labs if you don't already have recent bloodwork. Compared to $12,000–$16,000 for a year of cash-pay Wegovy, the compounded route makes long-term treatment financially feasible — which is exactly what sustainable weight loss requires.

Compounded semaglutide from a licensed 503A pharmacy delivers the same active molecule as Wegovy at roughly a tenth of the cost. The savings are real, but only when the compounding pharmacy is legitimate and the provider oversight is real. Compare all-in monthly prices, verify the pharmacy's licensure, and treat any suspiciously cheap quote as a data point about quality, not about savings.